Particulars |
|
|
|
Company Name
| Natco Pharma Ltd
| Year End
| 202303
|
Full Year |
Equity (₹ Cr.) |
35.82 |
B.V. (₹) |
284.50 |
Sales(₹ Cr.) |
2,351.00 |
NP (₹ Cr.) |
622.39 |
NP Var (%) |
491.00 |
Div% |
275.00 |
CPS(₹) |
43.20 |
EPS (₹) |
34.70 |
Traded Value(₹ Lakhs) |
1,043.78 |
52 Week High |
1,108.00 |
52 Week Low |
564.00 |
Price BSE |
1,022.00 |
Price NSE |
1,021.00 |
Market Capital (₹ Cr.) |
18,305.92 |
P/C Ratio |
23.70 |
P/E Ratio |
29.40 |
Price Vs.BV |
3.59 |
|
Latest Quarter |
Year End |
202312 |
Sales (₹ Cr.) |
625.30 |
NP(₹ Cr.) |
192.00 |
NP Var % |
415.00 |
Trailing Twelve Months |
Year End |
202312 |
Sales |
2,200.40 |
OPM |
22.70 |
NP |
356.00 |
NP Var (%) |
276.62 |
EPS |
67.65 |
PE |
15.11 |
|
|